Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index; 45 of the 212 sources its claims cite were checked for support.
Abstract
Bone tissue is continuously remodeled through the concerted actions of bone cells, which include bone resorption by osteoclasts and bone formation by osteoblasts, whereas osteocytes act as mechanosensors and orchestrators of the bone remodeling process. This process is under the control of local (e.g., growth factors and cytokines) and systemic (e.g., calcitonin and estrogens) factors that all together contribute for bone homeostasis. An imbalance between bone resorption and formation can result in bone diseases including osteoporosis. Recently, it has been recognized that, during bone remodeling, there are an intricate communication among bone cells. For instance, the coupling from bone resorption to bone formation is achieved by interaction between osteoclasts and osteoblasts. Moreover, osteocytes produce factors that influence osteoblast and osteoclast activities, whereas osteocyte apoptosis is followed by osteoclastic bone resorption. The increasing knowledge about the structure and functions of bone cells contributed to a better understanding of bone biology. It has been suggested that there is a complex communication between bone cells and other organs, indicating the dynamic nature of bone tissue. In this review, we discuss the current data about the structure and functions of bone cells and the factors that influence bone remodeling.
Overview
CoChat Summary
TL;DR
This narrative review summarizes bone tissue biology, focusing on the structure and functions of osteoblasts, bone lining cells, osteocytes, and osteoclasts, the extracellular matrix, and local/systemic regulators of bone remodeling. It emphasizes cell–cell coupling, osteocyte mechanosensing, estrogen’s role, and emerging endocrine functions of bone.
Key findings
- Bone contains four cell types: osteoblasts (4–6% of total resident bone cells) form bone; osteocytes (90–95% of total bone cells, lifespan up to 25 years) act as mechanosensors and orchestrators; osteoclasts resorb bone; bone lining cells participate in coupling and the basic multicellular unit.
- The osteocyte lacunocanalicular system includes up to 50 cytoplasmic processes per cell; osteocyte surface is estimated to be 400-fold larger than all Haversian and Volkmann systems and more than 100-fold larger than trabecular bone surface; the lacunar space is about 0.5–1.0 μm wide and the canalicular membrane distance is 50–100 nm.
- Bone remodeling proceeds through initiation of resorption, a transition/reversal phase, and bone formation; coupling involves matrix-released factors such as IGFs, TGF-β, BMPs, FGF, and PDGF, plus semaphorins (Sema4D, Sema3A) and ephrinB2/EphB4, while imbalance can cause osteoporosis or osteopetrosis.
- Estrogen maintains bone homeostasis by inhibiting osteoblast and osteocyte apoptosis, suppressing osteoclast formation/activity, inducing osteoclast apoptosis, and modulating RANKL/OPG and cytokines; bone endocrine actions include undercarboxylated osteocalcin effects on pancreas, adipose tissue, testis, and brain, and osteocyte FGF23 regulation of phosphate metabolism.
Methods
- Design: narrative review; the authors state they discuss current data about bone cells, bone matrix, factors influencing bone remodeling, and estrogen under physiological and pathological conditions.
- Data or sample: no primary sample or dataset; evidence is drawn from cited in vitro and in vivo studies and prior literature.
- Main analysis: narrative synthesis of structural, molecular, and functional findings; no systematic search, meta-analysis, or new experiments are reported.
Limitations
- Stated in the paper: bone lining cell functions are not completely understood; mechanisms of osteocyte mechanosensing and the precise osteocyte-derived osteoclastogenesis-stimulating factors remain uncertain; direct in vivo contact between mature osteoblasts and osteoclasts has not been demonstrated and is controversial; bone endocrine function is still poorly understood.
- Evident from the text: as a narrative review, it lacks a systematic search strategy, risk-of-bias assessment, or quantitative synthesis, and its conclusions depend on the selected cited literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
23 Valid · 2 Not valid · 92 Not checked · 16 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“For instance, in bones subjected to fatigue loading, viable osteocytes near the apoptotic ones express, besides high RANKL/OPG ratio, increased levels of vascular endothelial growth factor (VEGF) and monocyte chemoattractant protein-1 (CCL2) promoting an increase in local osteoclastogenesis [194, 195].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.8. Bone Remodeling Process
What the sources say
- Partly supportedcites [194] matched to “Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations” (2012) sourceExperimental — accuracy not yet measured
Kennedy et al. (2012) support most of the sentence: the Abstract (p.1) and Results > Immunohistochemistry show RANKL and VEGF staining peaking 100-300 um from the damage site in non-apoptotic osteocytes while caspase-3+ cells dominate the damage core, and the Discussion states the RANKL/OPG ratio shift 'favoring osteoclast formation'. However, the candidate genes and IHC targets were only RANKL, OPG, VEGF and M-CSF (Materials and Methods > Gene expression analyses; Results > Gene expression) - CCL2/MCP-1 is neither measured nor mentioned anywhere in our copy (searched: CCL2, monocyte chemoattractant protein-1, MCP-1, chemokine), so that part of the claim is not attributable to this source. Also, the pro-osteoclastogenic conclusion is inferred from signaling patterns, since tissues were analyzed 3 and 7 days after fatigue, 'prior to the first appearance of osteoclasts'. (LLM, conf=0.85)
- Disputedcites [195] matched to “MCP-1 Expression Is Specifically Regulated During Activation of Skeletal Repair and Remodeling” (2013) sourceExperimental — accuracy not yet measured
Our copy places CCL2/MCP-1 expression in osteoblasts, not osteocytes: the Abstract reports that by in-situ hybridization and immunohistochemistry 'MCP-1 mRNA and protein was localized in periosteal osteoblasts associated with woven bone formation at the fracture exit point, but not within osteocytes adjacent to the SFx', and the Discussion likewise concludes MCP-1 is secreted by osteoblasts as a candidate signal attracting osteoclasts and their precursors. The paper's model is rat ulnar stress fracture initiation by cyclic end-loading, and it explicitly contrasts this with 'adaptive' ulnar loading; nowhere does our copy report viable osteocytes near apoptotic ones, nor any measurement of VEGF or of a high RANKL/OPG ratio in osteocytes (RANKL/OPG appears only as a downstream pathway shared with gp-130 cytokines such as IL-6/IL-11, Discussion). Thus the cellular source and the VEGF/RANKL-OPG components attributed to this source are contrary to, or absent from, our copy. (LLM, conf=0.80)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“Bone lining cells functions are not completely understood, but it has been shown that these cells prevent the direct interaction between osteoclasts and bone matrix, when bone resorption should not occur, and also participate in osteoclast differentiation, producing osteoprotegerin (OPG) and the receptor activator of nuclear factor kappa-B ligand (RANKL) [14, 53].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.2. Bone Lining Cells
What the sources say
- Could not verifycites [14] matched to “A Physical Mechanism for Coupling Bone Resorption and Formation in Adult Human Bone” (2009) sourceExperimental — accuracy not yet measured
The Discussion describes bone-lining cells as poorly characterized and suggests they may be early osteoblast-lineage cells. It separately suggests that osteoblast precursors near differentiating pre-osteoclasts may express RANKL, but does not identify those precursors as bone-lining cells or say that bone-lining cells produce OPG. Searches for bone-lining cells with OPG, RANKL, and osteoclast differentiation found no passage establishing the claim. (LLM, conf=0.73)
- Not checked yetcites [53] 2000, Journal of Rehabilitation Research and Development
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Moreover, osteocyte apoptosis has been recognized as a chemotactic signal to osteoclastic bone resorption [70–73].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.3. Osteocytes
What the sources say
- Not checked yetcites [70] matched to “Identification of apoptotic changes in osteocytes in normal and pathological human bone” (1997) source
- Not checked yetcites [71] matched to “Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.” (2006) source
- Supportedcites [72] matched to “Apoptotic Osteocytes and the Control of Targeted Bone Resorption” (2014) source
The section on osteocyte apoptosis and osteoclast recruitment states that apoptotic osteocytes recruit osteoclasts to initiate bone resorption. It also identifies HMGB1, released by apoptotic osteocytic cells, as chemotactic for osteoclasts, while noting that the signals responsible in vivo remain to be identified. (LLM, conf=0.86)
- Supportedcites [73] matched to “Osteocyte-Driven Bone Remodeling” (2014) source
In section 3, “Dying osteocytes,” the review says apoptotic osteocytes precede resorption and may act as beacons for osteoclast recruitment. It also describes a potential chemotactic factor released during osteocyte apoptosis. The claim reflects that proposed link without identifying a specific signal. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Other recent evidence is that osteoclasts may also directly regulate the hematopoietic stem cell niche [112].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.4. Osteoclasts
What the sources say
- Supportedcites [112] matched to “Osteoclasts: more than ‘bone eaters’” (2014) source
The HSC-niche section says osteoclasts may directly regulate the hematopoietic stem cell niche. The Concluding Remarks repeat this qualified claim while noting that conflicting reports remain to be resolved. (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The systemic factors which are important to the maintenance of bone homeostasis include parathyroid hormone (PTH), calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, and estrogens [16, 147–150].”
§ Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells > 2. Bone Cells > 2.7. Local and Systemic Factor That Regulate Bone Homeostasis
What the sources say
- Partly supportedcites [16] matched to “Estrogen and the skeleton” (2012) sourceExperimental — accuracy not yet measured
Our copy supports only the sex-steroid part of the attributed list: the Overview of estrogen action on bone states that 'estrogen is perhaps the major systemic regulator of bone metabolism not only in women, but also in men,' and the same section (citing Falahati-Nini et al., ref 5) and ref 31 address androgens/testosterone as systemic bone regulators. The other four factors named in the claim — parathyroid hormone, calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol) and glucocorticoids — appear nowhere in our copy (searched: 'systemic factors parathyroid hormone calcitonin 1,25-dihydroxyvitamin D glucocorticoids', 'parathyroid hormone', 'calcitonin', 'glucocorticoids calcitonin vitamin D androgens'); every returned passage concerned estrogen actions, coupling factors in the bone remodeling compartment, or the reference list. Thus the paper does not enumerate the systemic hormonal repertoire the citing sentence attributes to it. (LLM, conf=0.72)
- Partly supportedcites [147] matched to “Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone” (2001) sourceExperimental — accuracy not yet measured
The Introduction (p. 1) of Calvi et al. 2001 supports only the PTH element of the list: it describes PTH as 'a major regulator of calcium homeostasis' that 'plays an important role in both bone formation and resorption' in the context of factors controlling osteoblast/osteoclast balance. Our copy nowhere mentions calcitonin, 1,25-dihydroxyvitamin D3 (calcitriol), glucocorticoids, androgens, or estrogens as systemic factors maintaining bone homeostasis (searched: calcitonin; estrogen/glucocorticoid/systemic hormonal regulators; 1,25-dihydroxyvitamin D3), so the remaining five items attributed to this source are unsupported. The paper's scope is the local action of activated PTH/PTHrP receptor in osteoblastic cells on cortical versus trabecular bone in transgenic mice, not a survey of systemic hormonal regulators. (LLM, conf=0.72)
- Not checked yetcites [148] 2002, BMC Musculoskeletal Disorders
- Not checked yetcites [149] matched to “Forty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS” (2002) source
- Not checked yetcites [150] matched to “Androgens and Bone” (2004) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 12 with their cited sources checked
Create a free account to see all 133 claims and to verify the 167 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vivo, a set of osteoblasts, all with similar morphologies, lay down osteoid on active bone-forming surfaces.268”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [268]
Citations
Cites
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246 · cited 2×
“The expressions of Runtrelated transcription factors 2,Distal-less homeobox 5 (Dlx5), and osterix (Osx) are crucial for osteoblast differentiation [22, 26].”
BackgroundKomori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 3×
“Besides osteoclasts and osteoblasts, it has been demonstrated that osteocytes play key roles during the bone remodeling cycle [8].”
BackgroundNormal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878 · cited 2×
“Together, these factors promote the activation of transcription factors [81, 82] and gene expression in osteoclasts [83, 84].”
BackgroundFunctions of RANKL/RANK/OPG in bone modeling and remodeling
Boyce, B. F., & Xing, L. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.018 · Cited by 1,844 · cited 1×
“On the other hand, another factor called osteoprotegerin (OPG), which is produced by a wide range of cells including osteoblasts, stromal cells, and gingival and periodontal fibroblasts [87–89], binds to RANKL, preventing the RANK/RANKL interaction and, consequently, inhibiting the osteoclastogenesis [87] (Figure 5).”
Background
Research works printed but not linked: 15
- 2004, Histology and Histopathology, 19, 1325
- 1998, The nature of the mineral phase in bone, 23
- 1990, Bone-forming cells in clinical conditions, 351
- 1989, Scanning Microscopy, 3, 953
- 2000, Journal of Rehabilitation Research and Development, 37, 189
- 1999, The FASEB Journal, 13, S101
- 1999, Laboratory Investigation, 79, 83
- 2008, Journal of Musculoskeletal Neuronal Interactions, 8, 204
- 2005, Journal of Musculoskeletal Neuronal Interactions, 5, article 316
- 1972, Bone resorption and matrix hexosamine labeling, 327
- 2008, Integrins and adhesion molecules, 385
- 2004, Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 278, 505
- 2002, BMC Musculoskeletal Disorders, 7, 3
- 1997, Endocrine Society Journals and Publications, 82, 3128
- 2006, Journal of Musculoskeletal Neuronal Interactions, 6, 354
Cited by
Items 101–200 of 1,003
Yılmaz, E., Çakıroğlu, B., Gökçe, A., Fındık, F., Gülsoy, H. Ö., Gülsoy, N., Mutlu, Ö., & Özacar, M. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.03.078 · Cited by 127
Regulation of Runx2 by MicroRNAs in osteoblast differentiation
Narayanan, A. M., Srinaath, N., Rohini, M., & Selvamurugan, N. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116676 · Cited by 125
Designing of gradient scaffolds and their applications in tissue regeneration
Pattnaik, A., Sanket, A. S., Pradhan, S., Sahoo, R., Das, S., Pany, S., Douglas, T., Dandela, R., Liu, Q., Rajadas, J., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122078 · Cited by 123
Material‐Assisted Strategies for Osteochondral Defect Repair
Lesage, C., Lafont, M., Guihard, P. J., Weiss, P., Guicheux, J., & Delplace, V. (2022) · Advanced Science · doi:10.1002/advs.202200050 · Cited by 121
Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease
Chen, Y., Wu, X., Li, J., Jiang, Y., Xu, K., & Su, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909408 · Cited by 120
Bench-to-bedside strategies for osteoporotic fracture: From osteoimmunology to mechanosensation
Xie, Y., Zhang, L., Xiong, Q., Gao, Y., Ge, W., & Tang, P. (2019) · Bone Research · doi:10.1038/s41413-019-0066-7 · Cited by 119
Smart/stimuli-responsive hydrogels: State-of-the-art platforms for bone tissue engineering
El‐Husseiny, H. M., Mady, E. A., El‐Dakroury, W. A., Zewail, M. B., Noshy, M., Abdelfatah, A. M., & Doghish, A. S. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101560 · Cited by 117
A mechanosensitive lipolytic factor in the bone marrow promotes osteogenesis and lymphopoiesis
Peng, H., Hu, B., Xie, L.-Q., Su, T., Li, C.-J., Liu, Y., Yang, M., Xiao, Y., Feng, X., Zhou, R., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.05.009 · Cited by 103
Adipose-Derived Stem Cells in Bone Tissue Engineering: Useful Tools with New Applications
Storti, G., Scioli, M. G., Kim, B., Orlandi, A., & Cervelli, V. (2019) · Stem Cells International · doi:10.1155/2019/3673857 · Cited by 115
Advanced applications of strontium-containing biomaterials in bone tissue engineering
Sheng, X., Li, C., Wang, Z., Xu, Y. S., Sun, Y., Zhang, W., Liu, H., & Wang, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100636 · Cited by 115
Tetracyclines and bone: Unclear actions with potentially lasting effects
Warner, A. J., Hathaway‐Schrader, J. D., Lubker, I. M., Davies, C., & Novince, C. M. (2022) · Bone · doi:10.1016/j.bone.2022.116377 · Cited by 114
Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases
Minty, M., Canceill, T., Sérino, M., Burcelin, R., Tercé, F., & Blasco‐Baqué, V. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09526-8 · Cited by 113
Scaffold-Based Tissue Engineering Strategies for Osteochondral Repair
Fu, J.-N., Wang, X., Yang, M., Chen, Y., Zhang, J., Deng, R., Zhang, Z., Yu, J., & Yuan, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.812383 · Cited by 113
Wu, X., Li, F., Dang, L., Liang, C., Lü, A., & Zhang, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00076 · Cited by 112
Setiawati, R., & Rahardjo, P. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82452 · Cited by 111
Trubiani, O., Marconi, G. D., Pierdomenico, S. D., Piattelli, A., Diomede, F., & Pizzicannella, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20204987 · Cited by 111
Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research
Sun, M., Wu, X., Yu, Y., Wang, L., Xie, D., Zhang, Z., Chen, L., Lü, A., Zhang, G., & Li, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576110 · Cited by 111
Advances in the Fabrication of Scaffold and 3D Printing of Biomimetic Bone Graft
Bisht, B., Hope, A., Mukherjee, A., & Paul, M. K. (2021) · Annals of Biomedical Engineering · doi:10.1007/s10439-021-02752-9 · Cited by 111
Jiménez, M., Abradelo, C., Román, J. S., & Rojo, L. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb02738b · Cited by 110
Wang, X., Schröder, H. C., & Müller, W. E. G. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00241j · Cited by 109
Assessment of the morphology and dimensional accuracy of 3D printed PLA and PLA/HAp scaffolds
Gendviliene, I., Simoliunas, E., Rekstyte, S., Malinauskas, M., Zaleckas, L., Jegelevicius, D., Bukelskiene, V., & Rutkunas, V. (2020) · Journal of the Mechanical Behavior of Biomedical Materials · doi:10.1016/j.jmbbm.2020.103616 · Cited by 97
Biological Roles and Delivery Strategies for Ions to Promote Osteogenic Induction
Bosch-Rué, È., Díez-Tercero, L., Giordano-Kelhoffer, B., Delgado, L. M., Bosch, B. M., Hoyos‐Nogués, M., Mateos‐Timoneda, M. A., Tran, P. A., Gil, F. J., & Pérez, R. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.614545 · Cited by 109
New Insights into Monogenic Causes of Osteoporosis
Mäkitie, R. E., Costantini, A., Kämpe, A., Alm, J. J., & Mäkitie, O. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00070 · Cited by 108
Synthetic and Marine-Derived Porous Scaffolds for Bone Tissue Engineering
Neto, A. S., & Ferreira, J. M. F. (2018) · Materials · doi:10.3390/ma11091702 · Cited by 108
Deregulated miRNAs in bone health: Epigenetic roles in osteoporosis
Bellavia, D., Luca, A. D., Carina, V., Costa, V., Raimondi, L., Salamanna, F., Alessandro, R., Fini, M., & Giavaresi, G. (2019) · Bone · doi:10.1016/j.bone.2019.02.013 · Cited by 108
Al-Ghafari, A. B., Elmorsy, E. M., Fikry, E., Alrowaili, M. G., & Carter, W. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225341 · Cited by 107
Toll-like receptors as a key regulator of mesenchymal stem cell function: An up-to-date review
Shirjang, S., Mansoori, B., Solali, S., Hagh, M. F., & Shamsasenjan, K. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.12.005 · Cited by 106
Molecular and cellular mechanisms linking air pollution and bone damage
Prada, D., López, G., Solleiro-Villavicencio, H., García-Cuellar, C. M., & Baccarelli, A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109465 · Cited by 106
Janarthanan, G., Kim, I. G., Chung, E., & Noh, I. (2019) · Biomaterials Research · doi:10.1186/s40824-018-0153-7 · Cited by 105
Reactive Oxygen Species (ROS)-Responsive Biomaterials for the Treatment of Bone-Related Diseases
Ren, X., Liu, H., Wu, X., Weng, W., Wang, X., & Su, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.820468 · Cited by 106
A Review of 3D Printed Bone Implants
Li, Z., Wang, Q., & Liu, G. (2022) · Micromachines · doi:10.3390/mi13040528 · Cited by 105
The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases
Kolb, A. D., & Bussard, K. M. (2019) · Cancers · doi:10.3390/cancers11071020 · Cited by 105
The extracellular matrix of hematopoietic stem cell niches
Lee‐Thedieck, C., Schertl, P., & Klein, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114069 · Cited by 104
Kérourédan, O., Bourget, J., Rémy, M., Crauste–Manciet, S., Kalisky, J., Catros, S., Thébaud, N., & Devillard, R. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-019-6230-1 · Cited by 102
Microfluidic platform for studying osteocyte mechanoregulation of breast cancer bone metastasis
Mei, X., Middleton, K., Shim, D., Wan, Q., Xu, L., Ma, Y.-H. V., Devadas, D., Walji, N., Wang, L., Young, E. W. K., et al. (2019) · Integrative Biology · doi:10.1093/intbio/zyz008 · Cited by 87
Huang, B., Vyas, C., Byun, J. J., El-Newehy, M., Huang, Z., & Bártolo, P. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110374 · Cited by 96
Li, D., Cai, L., Meng, R., Feng, Z., & Xu, Q. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051660 · Cited by 102
Diomede, F., D’Aurora, M., Gugliandolo, A., Merciaro, I., Ettorre, V., Bramanti, A., Piattelli, A., Gatta, V., Mazzon, E., Fontana, A., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s162836 · Cited by 101
Targeting autophagy in osteoporosis: From pathophysiology to potential therapy
Li, X., Xu, J., Dai, B., Wang, X., Guo, Q., & Qin, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101098 · Cited by 100
Mechanistic Insight into Orthodontic Tooth Movement Based on Animal Studies: A Critical Review
Jeon, H. H., Teixeira, H. S., & Tsai, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081733 · Cited by 102
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma
Anand, N., Peh, K. H., & Kolesar, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032858 · Cited by 100
Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis
Kugyelka, R., Kohl, Z., Olasz, K., Mikecz, K., Rauch, T. A., Glant, T. T., & Boldizsár, F. (2016) · Mediators of Inflammation · doi:10.1155/2016/6145810 · Cited by 100
RANKL and RANK: From Mammalian Physiology to Cancer Treatment
Rao, S., Cronin, S. J. F., Sigl, V., & Penninger, J. M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.001 · Cited by 100
Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis
Arjmand, B., Sarvari, M., Alavi-Moghadam, S., Payab, M., Goodarzi, P., Gilany, K., Mehrdad, N., & Larijani, B. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00430 · Cited by 99
The Application of Hyaluronic Acid-Based Hydrogels in Bone and Cartilage Tissue Engineering
Li, H., Qi, Z., Zheng, S., Chang, Y., Kong, W., Fu, C., Yu, Z., Yang, X., & Pan, S. (2019) · Advances in Materials Science and Engineering · doi:10.1155/2019/3027303 · Cited by 96
Bone Scaffolds: An Incorporation of Biomaterials, Cells, and Biofactors
Bahraminasab, M., Janmohammadi, M., Arab, S., Talebi, A., Nooshabadi, V. T., Koohsarian, P., & Nourbakhsh, M. S. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00920 · Cited by 96
Daponte, V., Henke, K., & Drissi, H. (2024) · eLife · doi:10.7554/elife.95083 · Cited by 96
Sensini, A., Massafra, G., Gotti, C., Zucchelli, A., & Cristofolini, L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.645544 · Cited by 95
Deciphering the Relevance of Bone ECM Signaling
Alcorta-Sevillano, N., Macías, I., Infante, A., & Rodríguez, C. I. (2020) · Cells · doi:10.3390/cells9122630 · Cited by 95
The role of statins in the differentiation and function of bone cells
Chamani, S., Liberale, L., Mobasheri, L., Montecucco, F., Al‐Rasadi, K., Jamialahmadi, T., & Sahebkar, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13534 · Cited by 94
Bone Organoids: Recent Advances and Future Challenges
Zhao, D., Saiding, Q., Li, Y., Tang, Y., & Cui, W. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302088 · Cited by 94
Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases
Oton, L., Mazziotta, C., Iaquinta, M. R., Mazzoni, E., Nocini, R., Trevisiol, L., D’Agostino, A., Tognon, M. G., Rotondo, J. C., & Martini, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031500 · Cited by 93
The role of PIEZO ion channels in the musculoskeletal system
Savadipour, A., Palmer, D., Ely, E. V., Collins, K. H., Garcia‐Castorena, J. M., Harissa, Z., Kim, Y. S., Oestrich, A., Qu, F., Rashidi, N., et al. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00544.2022 · Cited by 93
Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis
El‐Gazzar, A., & Högler, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020625 · Cited by 95
Cellular and Molecular Mechanisms Associating Obesity to Bone Loss
Forte, Y. S., Renovato‐Martins, M., & Barja‐Fidalgo, C. (2023) · Cells · doi:10.3390/cells12040521 · Cited by 91
Carotenuto, F., Politi, S., Haq, A. U., Matteis, F. D., Tamburri, E., Terranova, M. L., Teodori, L., Pasquo, A., & Nardo, P. D. (2022) · Micromachines · doi:10.3390/mi13050780 · Cited by 90
Nanomedicine for safe healing of bone trauma: Opportunities and challenges
Behzadi, S., Luther, G. A., Harris, M. B., Farokhzad, O. C., & Mahmoudi, M. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.005 · Cited by 90
Bone Defect Reconstruction Via Endochondral Ossification: A Developmental Engineering Strategy
Fu, R., Liu, C., Li, J., Yan, Y., Xie, Y., Li, Q., & Huang, R. (2020) · Journal of Tissue Engineering · doi:10.1177/20417314211004211 · Cited by 89
Osteoporosis and cardiovascular disease: a review
Azeez, T. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08088-4 · Cited by 89
Ali, N., Sohail, R., Jaffer, S. R., Siddique, S., Kaya, B., Atowoju, I., Imran, A., Wright, W., Pamulapati, S., Choudhry, F., et al. (2023) · Cureus · doi:10.7759/cureus.43053 · Cited by 89
Zhang, L., Guan, Q., Wang, Z., Feng, J., Zou, J., & Gao, B. (2023) · Aging and Disease · doi:10.14336/ad.2023.1115 · Cited by 90
An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells
Ferraz, M. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073836 · Cited by 89
Biotherapeutic Effect of Gingival Stem Cells Conditioned Medium in Bone Tissue Restoration
Diomede, F., Gugliandolo, A., Scionti, D., Merciaro, I., Cavalcanti, M. F. X. B., Mazzon, E., & Trubiani, O. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020329 · Cited by 88
Targeting chronic inflammation as a potential adjuvant therapy for osteoporosis
Livshits, G., & Kalinkovich, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120847 · Cited by 88
Cheng, Y. F., Cheng, G., Xie, C., Yin, C., Dong, X., Li, Z., Zhou, X. M., Wang, Q., Deng, H., & Li, Z. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001646 · Cited by 87
van Hengel, I. A. J., Tierolf, M. W. A. M., Fratila-Apachitei, L. E., Apachitei, I., & ZADPOOR, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073800 · Cited by 87
Lavin, K. M., Coen, P. M., Baptista, L. C., Bell, M. B., Drummer, D., Harper, S. A., Lixandrão, M. E., McAdam, J. S., O'Bryan, S. M., Ramos, S., et al. (2022) · Comprehensive Physiology · doi:10.1002/cphy.c200033 · Cited by 60
Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism
Lisowska, B., Kosson, D., & Domaracka, K. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s164562 · Cited by 87
Wu, J., Miao, G., Zheng, Z., Li, Z., Ren, W., Wu, C., Li, Y., Huang, Z., Yang, L., & Guo, L. (2018) · Journal of Biomaterials Applications · doi:10.1177/0885328218810269 · Cited by 87
Silva‐Rojas, R., Laporte, J., & Böhm, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.604941 · Cited by 87
Tyson, J. J., Bundy, K., Roach, C., Douglas, H., Ventura, V., Segars, M. F., Schwartz, O., & Simpson, C. L. (2020) · Bioengineering · doi:10.3390/bioengineering7030088 · Cited by 86
Chuysinuan, P., Nooeaid, P., Thanyacharoen, T., Techasakul, S., Pavasant, P., & Kanjanamekanant, K. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.132 · Cited by 86
Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function
Alonso‐Pérez, A., Franco‐Trepat, E., Guillán‐Fresco, M., Mora, A. J., López, V., Pino, J., Gualillo, O., & Gómez, R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00504 · Cited by 86
Youness, R. A., El-deen, D. M. T., & Taha, M. A. (2022) · Silicon · doi:10.1007/s12633-022-02207-3 · Cited by 85
Bone metabolism – an underappreciated player
Choi, I. A., Umemoto, A., Mizuno, M., & Park‐Min, K. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00010-9 · Cited by 85
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
Ming, J., Cronin, S. J. F., & Penninger, J. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01283 · Cited by 84
Li, Z., Wang, P., Li, J., Xie, Z., Cen, S., Li, M., Liu, W., Ye, G., Guan, Z., Ma, M., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03869-4 · Cited by 84
Jarkov, V., Allan, S. J., Bowen, C., & Khanbareh, H. (2021) · International Materials Reviews · doi:10.1080/09506608.2021.1988194 · Cited by 85
Chi, J., Wang, M., Chen, J., Hu, L., Chen, Z., Backman, L. J., & Zhang, W. (2022) · Biomimetics · doi:10.3390/biomimetics7030131 · Cited by 84
Bone structure: from cortical to calcium
Black, J., & Tadros, B. J. (2020) · Orthopaedics and Trauma · doi:10.1016/j.mporth.2020.03.002 · Cited by 83
Mimicking bone microenvironment: 2D and 3D in vitro models of human osteoblasts
Yuste, I., Luciano, F. C., González‐Burgos, E., Lalatsa, A., & Serrano, D. R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105626 · Cited by 83
Physiology of ageing of the musculoskeletal system
Boros, K., & Freemont, A. J. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.003 · Cited by 84
The role of autophagy in bone homeostasis
Guo, Y., Su, T., Yang, M., Li, C., Guo, Q., Xiao, Y., Huang, Y., Liu, Y., & Luo, X. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30111 · Cited by 82
Bone-to-Brain: A Round Trip in the Adaptation to Mechanical Stimuli
Gerosa, L., & Lombardi, G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.623893 · Cited by 76
3D printing of inorganic-biopolymer composites for bone regeneration
van der Heide, D., Cidonio, G., Stoddart, M. J., & D’Este, M. (2022) · Biofabrication · doi:10.1088/1758-5090/ac8cb2 · Cited by 82
Wei, F., Li, Z., Crawford, R., Xiao, Y., & Zhou, Y. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2947 · Cited by 82
Comprehensive Survey on Nanobiomaterials for Bone Tissue Engineering Applications
Kumar, P., Saini, M., Dehiya, B. S., Sindhu, A., Kumar, V., Kumar, R., Lamberti, L., Pruncu, C. I., & Thakur, R. (2020) · Nanomaterials · doi:10.3390/nano10102019 · Cited by 81
Hong, G., Chen, Z., Han, X., Zhou, L., Pang, F., Wu, R., Shen, Y.-S., He, X., Hong, Z., Li, Z., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.392 · Cited by 81
Bone Cell Exosomes and Emerging Strategies in Bone Engineering
Vig, S., & Fernandes, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10040767 · Cited by 81
Biodegradable Materials for Tissue Engineering: Development, Classification and Current Applications
Modrák, M., Trebuňová, M., Balogová, A. F., Hudák, R., & Živčák, J. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14030159 · Cited by 81
Clinical Potential of Mesenchymal Stem Cell-Derived Exosomes in Bone Regeneration
Torrecillas-Baena, B., Pulido-Escribano, V., Dorado, G., Gálvez-Moreno, M. Á., Camacho-Cardeñosa, M., & Casado‐Díaz, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134385 · Cited by 81
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis
Park, S., & Miller, B. J. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.012 · Cited by 81
Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target
Amin, N., Clark, C. C. T., Taghizadeh, M., & Jafarnejad, S. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.126417 · Cited by 81
Impact of PEG sensitization on the efficacy of PEG hydrogel-mediated tissue engineering
Isaac, A., Phillips, S. Y. R., Ruben, E., Estes, M. D., Rajavel, V., Baig, T., Paleti, C., Landsgaard, K. A., Lee, R. H., Guda, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46327-3 · Cited by 80
A Review on the Effects of Bisphenol A and Its Derivatives on Skeletal Health
Chin, K., Pang, K.-L., & Mark-Lee, W. F. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.25634 · Cited by 80
Osteoporosis Screening: Applied Methods and Technological Trends.
de Oliveira, M. D., Moraes, R., Castanha, E., Prevedello, A. S., Filho, J. V., Bussolaro, F. A., & Cava, D. G. (2022) · Medical Engineering and Physics · doi:10.1016/j.medengphy.2022.103887 · Cited by 58
Autophagy as a target for glucocorticoid-induced osteoporosis therapy
Shen, G., Ren, H. J., Shang, Q., Qiu, T., Yu, X., Zhang, Z., Huang, J., Zhao, W., Zhang, Y., Liang, D., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2776-1 · Cited by 80
Mederle, O. A., Balaş, M., Ioanoviciu, S. D., Gurban, C., Tudor, A., & Borza, C. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s170111 · Cited by 81
Recent advances in bone-targeted therapy
Shi, C., Wu, T., He, Y., Zhang, Y., & Fu, D. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107473 · Cited by 79
The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma
Rossi, F., Tortora, C., Punzo, F., Bellini, G., Argenziano, M., Paola, A. D., Torella, M., & Perrotta, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081919 · Cited by 78
Metadata
- Authors
- Florencio-Silva, R., Sasso, G. R. D. S., Sasso-Cerri, E., Simões, M. J., & Cerri, P. S.
- Affiliations
- Department of Morphology and Genetics, Laboratory of Histology and Structural Biology, Federal University of São Paulo, 04023-900 São Paulo, SP, Brazil
- Universidade Federal de São Paulo (BR)
- Department of Morphology, Laboratory of Histology and Embryology, Dental School, Universidade Estadual Paulista (UNESP), 14801-903 Araraquara, SP, Brazil
- Universidade Estadual Paulista (Unesp) (BR)
- Corresponding author
- Cerri, Paulo Sérgio
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-17
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4515490
- OpenAlex
- W1594526962
- Cited by
- 2,044
- References
- 209
- Citations by year
- 2026: 157 · 2025: 238 · 2024: 265 · 2023: 286 · 2022: 254 · 2021: 241 · 2020: 219 · 2019: 169 · 2018: 110 · 2017: 64 · 2016: 35 · 2015: 5
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2010/10391-9, 2012/19428-8, 2012/22666-8)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- bone remodeling, bone cells, osteoclasts, osteoblasts, osteocytes, bone resorption, bone formation, bone homeostasis, osteocyte apoptosis, osteoporosis, calcitonin, estrogen, growth factors, cytokines, mechanosensing, intercellular communication
- MeSH terms
- Animals, Bone and Bones, Calcification, Physiologic, Cell Communication, Humans, Models, Biological, Osteoblasts, Osteoclasts, Structure-Activity Relationship, Bone Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.